PRPH Stock Analysis: Buy, Sell, or Hold?
PRPH - ProPhase Labs, Inc. Common Stock (DE)
$0.36
-0.08 (-18.97%)
▼
5d:
-39.58%
30d:
+157.16%
90d:
-33.69%
WAIT
LOW Confidence
Analysis Updated: Jan 2, 2026 12:00 AM ET
Earnings: Apr 01, 2026
0d
Get Alerted When PRPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PRPH is down 39.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PRPH is down 39.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PRPH is currently trading at $0.36, which is considered fair based on recent price action.
Technical Outlook: Technically, PRPH is showing sideways momentum. Immediate support is located at $0.08, while resistance sits at $1.15. Short-term momentum is weak, with the stock down 19.0% recently.
Market Sentiment: PRPH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.80 (+3705.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRPH is showing sideways momentum. Immediate support is located at $0.08, while resistance sits at $1.15. Short-term momentum is weak, with the stock down 19.0% recently.
Market Sentiment: PRPH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.80 (+3705.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
56/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
76.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BEARISH: Downward momentum (-19.0%)
- BULLISH: Trading 3705.8% below Wall St target ($13.80)
- WARNING: Recommendation downgraded due to -39.6% 5-day decline - wait for stabilization
Support & Resistance Levels
Support Level
$0.08
Resistance Level
$1.15
Current Trend
Sideways
Technical data as of
Jan 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.09
Wall Street Target
$13.80
(+3705.8%)
Revenue Growth (YoY)
-37.6%
Earnings Growth (YoY)
-95.2%
Share & Embed Analysis
Last updated: April 21, 2026 4:54 AM ET
Data refreshes hourly during market hours. Next update: 5:54 AM
Data refreshes hourly during market hours. Next update: 5:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$658 | 63 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$261 | 63 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$130 | 58 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$259 | 58 HOLD |
